EPISODE · Apr 24, 2025 · 9 MIN
Episode 11 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 3 Tailoring Treatment: The Role of Serotype Testing
from Practice Point® CME Podcasts: Expert Discussions in Rare Diseases™
Join Dr. Nicholas Silvestri in this 9-minute, special edition podcast series on myasthenia gravis (MG). Today’s podcast titled, Tailoring Treatment: The Role of Serotype Testing, discusses the impact of serotype testing on treatment decisions, including differences in therapeutic approaches for AChR-positive, MuSK-positive, and LRP4-positive patients.Launch Date: April 24, 2025Release Date: April 24, 2025Expiration Date: March 31, 2026FACULTYNicholas Silvestri, MD, FAANProfessor of Neurology, Associate Dean for Student and Academic AffairsDepartment of NeurologyJacobs School of Medicine & Biomedical SciencesThis podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.
Embed this episode
NOW PLAYING
Episode 11 - Emerging Evidence in Myasthenia Gravis: A Special Edition Podcast Series - Part 3 Tailoring Treatment: The Role of Serotype Testing
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.